Increased Cardiovascular Risk in South African Patients with Addison’s Disease-Reference-Cited by-同舟云学术

Increased Cardiovascular Risk in South African Patients with Addison’s Disease

Published:2013-08-05 Issue:12 Volume:45 Page:905-910
ISSN:0018-5043
Container-title:Hormone and Metabolic Research
language:en
Short-container-title:Horm Metab Res

Author:

Ross I.¹,Bergthorsdottir R.²,Levitt N.¹,Schatz D.³,Johannsson G.²,Marais A.⁴

Affiliation:

1. Division of Endocrinology Department of Medicine University of Cape Town, Cape Town, South Africa

2. Department of Endocrinology, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden

3. Department of Paediatrics, University of Florida, Florida, USA

4. Division of Chemical Pathology, Clinical Laboratory Sciences, National Health Laboratory, Service Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa

Publisher

Georg Thieme Verlag KG

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0033-1351259.pdf

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conventional steroids vs. dual-release hydrocortisone on metabolic, cardiovascular, and bone outcomes in adrenal insufficiency: a 10-year study;European Journal of Endocrinology;2024-08-22

2. Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency;Frontiers in Endocrinology;2023-09-11

3. Coronary artery disease in a patient with Addison’s disease: a case report and literature review;BMC Cardiovascular Disorders;2023-01-29

4. Patients with adrenal insufficiency have cardiovascular features associated with hypovolemia;Endocrine;2020-08-19

5. Serum Visfatin does not seem to be a Useful Marker to Guide Glucocorticoid Substitution in Adrenal Insufficiency;Hormone and Metabolic Research;2020-04-06